
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
On June 04, 2026, Alcon Inc (ALC) shares rose 3.7% today, closing at $66.58. The stock has seen considerable volatility over the past year, with a 52-week high

Alcon receives a buy rating, driven by the launch of Tryptyr in the mature dry eye disease market. Tryptyr's unique mechanism and rapid tear production differentiate it, but commercial adoption hinges on refill rates, payer coverage, and patient persistence. ALC's robust commercial footprint and strong balance sheet support ongoing R&D, M&A, dividends, and buybacks, mitigating financing risks.

Alcon's Surgical and Vision Care units returned to 6% growth in Q1 2026, but tariffs, macro pressure and fierce competition still loom.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

ST. CATHARINES, Ontario--(BUSINESS WIRE)--Algoma Central Corporation (TSX: ALC) ("Algoma", the "Company") today reported its results for the three months ended March 31, 2026. Algoma reported first quarter revenues of $127,781, compared to revenues of $107,201 in 2025. Net earnings for the first quarter were $2,224 compared to a loss of $23,280 in 2025. Earnings in 2026 include one-time net gains totaling $18,881 in the period. Due to the closing of the canal system and the winter weather condi.

Alcon Inc. (ALC) Q1 2026 Earnings Call Transcript

Swiss-American eye care company Alcon reported a 10% rise in its quarterly revenue, citing recent product launches as main drivers.

GENEVA--(BUSINESS WIRE)--New Product Launches Drive Alcon's First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds.

Investors with an interest in Medical - Instruments stocks have likely encountered both Alcon (ALC) and Penumbra (PEN). But which of these two stocks presents investors with the better value opportunity right now?

GENEVA--(BUSINESS WIRE)--Alcon Announces Results of 2026 Annual General Meeting.

On April 21, 2026, Alcon Inc (ALC) shares fell 3.1% today to a current price of $77.82. This decline comes amid a 52-week range of $71.55 to $99.20, reflecting

Here is how Alcon (ALC) and Brainsway Ltd. Sponsored ADR (BWAY) have performed compared to their sector so far this year.

Representative Josh Gottheimer (Democratic-New Jersey) recently sold shares of Crown Castle Inc. (NYSE: CCI). In a filing disclosed on April 08th, the Representative disclosed that they had sold between $1,001 and $15,000 in Crown Castle stock on March 24th. The trade occurred in the Representative's "MORGAN STANLEY - SELECT UMA ACCOUNT # 1" account. Representative Josh

Representative Josh Gottheimer (Democratic-New Jersey) recently sold shares of La-Z-Boy Incorporated (NYSE: LZB). In a filing disclosed on April 08th, the Representative disclosed that they had sold between $1,001 and $15,000 in La-Z-Boy stock on March 12th. The trade occurred in the Representative's "MORGAN STANLEY - SELECT UMA ACCOUNT # 1" account. Representative Josh Gottheimer also

Representative Josh Gottheimer (Democratic-New Jersey) recently sold shares of ENN Energy Holdings Ltd. (OTCMKTS:XNGSY). In a filing disclosed on April 08th, the Representative disclosed that they had sold between $1,001 and $15,000 in ENN Energy stock on March 24th. The trade occurred in the Representative's "MORGAN STANLEY - SELECT UMA ACCOUNT # 1" account. Representative

Representative Josh Gottheimer (Democratic-New Jersey) recently sold shares of Infineon Technologies AG (OTCMKTS:IFNNY). In a filing disclosed on April 08th, the Representative disclosed that they had sold between $1,001 and $15,000 in Infineon Technologies stock on March 12th. The trade occurred in the Representative's "MORGAN STANLEY - SELECT UMA ACCOUNT # 1" account. Representative Josh

Representative Josh Gottheimer (Democratic-New Jersey) recently sold shares of HDFC Bank Limited (NYSE: HDB). In a filing disclosed on April 08th, the Representative disclosed that they had sold between $1,001 and $15,000 in HDFC Bank stock on March 12th. The trade occurred in the Representative's "MORGAN STANLEY - SELECT UMA ACCOUNT # 1" account. Representative Josh

Representative Josh Gottheimer (Democratic-New Jersey) recently sold shares of Phreesia, Inc. (NYSE: PHR). In a filing disclosed on April 08th, the Representative disclosed that they had sold between $1,001 and $15,000 in Phreesia stock on March 5th. The trade occurred in the Representative's "MORGAN STANLEY - SELECT UMA ACCOUNT # 1" account. Representative Josh Gottheimer also

Representative Josh Gottheimer (Democratic-New Jersey) recently sold shares of First Watch Restaurant Group, Inc. (NASDAQ: FWRG). In a filing disclosed on April 08th, the Representative disclosed that they had sold between $1,001 and $15,000 in First Watch Restaurant Group stock on March 5th. The trade occurred in the Representative's "MORGAN STANLEY - SELECT UMA ACCOUNT #

Representative Josh Gottheimer (Democratic-New Jersey) recently sold shares of CBIZ, Inc. (NYSE: CBZ). In a filing disclosed on April 08th, the Representative disclosed that they had sold between $1,001 and $15,000 in CBIZ stock on March 5th. The trade occurred in the Representative's "MORGAN STANLEY - SELECT UMA ACCOUNT # 1" account. Representative Josh Gottheimer also

Representative Josh Gottheimer (Democratic-New Jersey) recently bought shares of Air Products and Chemicals, Inc. (NYSE: APD). In a filing disclosed on April 08th, the Representative disclosed that they had bought between $1,001 and $15,000 in Air Products and Chemicals stock on March 5th. The trade occurred in the Representative's "MORGAN STANLEY - SELECT UMA ACCOUNT #

Representative Josh Gottheimer (Democratic-New Jersey) recently sold shares of Intapp, Inc. (NASDAQ: INTA). In a filing disclosed on April 08th, the Representative disclosed that they had sold between $1,001 and $15,000 in Intapp stock on March 12th. The trade occurred in the Representative's "MORGAN STANLEY - SELECT UMA ACCOUNT # 1" account. Representative Josh Gottheimer also

Representative Josh Gottheimer (Democratic-New Jersey) recently bought shares of Fabrinet (NYSE: FN). In a filing disclosed on April 08th, the Representative disclosed that they had bought between $1,001 and $15,000 in Fabrinet stock on March 24th. The trade occurred in the Representative's "MORGAN STANLEY - SELECT UMA ACCOUNT # 1" account. Representative Josh Gottheimer also recently

Representative Josh Gottheimer (Democratic-New Jersey) recently bought shares of Sea Limited Sponsored ADR (NYSE: SE). In a filing disclosed on April 08th, the Representative disclosed that they had bought between $1,001 and $15,000 in SEA stock on March 10th. The trade occurred in the Representative's "MORGAN STANLEY - SELECT UMA ACCOUNT # 1" account. Representative Josh

Representative Josh Gottheimer (Democratic-New Jersey) recently sold shares of Columbia Banking System, Inc. (NASDAQ: COLB). In a filing disclosed on April 08th, the Representative disclosed that they had sold between $1,001 and $15,000 in Columbia Banking System stock on March 5th. The trade occurred in the Representative's "MORGAN STANLEY - SELECT UMA ACCOUNT # 1" account.

STAAR Surgical Company has seen a dramatic valuation reset, now trading at a $1bn market cap after failed acquisition talks and underwhelming US growth. Q1 2026 net sales are expected to exceed $90m, driven by a strong rebound in China and signaling potential for record annual revenues. Despite operational challenges and competitive pressures, STAA's proprietary Collamer lens and expanded US indications provide incremental growth opportunities.

Vancouver, British Columbia--(Newsfile Corp. - April 9, 2026) - Mexican Gold Mining Corp. (TSXV: MEX) ("Mexican Gold" or the "Purchaser") and Alcon Silver Corp. ("Alcon" or the "Company") are pleased to announce that they have entered into an arrangement agreement (the "Arrangement Agreement") dated April 8, 2026, pursuant to which Mexican Gold will acquire all of the issued and outstanding common shares of Alcon (the "Company Shares") in exchange for newly issued common shares in the capital of Mexican Gold (the "Consideration Shares") by way of a court-approved plan of arrangement under the Business Corporations Act (British Columbia) (the "Arrangement"). Under the terms of the Arrangement Agreement, Alcon shareholders will receive one post-consolidated share of Mexican Gold (see below for details regarding the proposed consolidation) for each Company Share held such that, following the effective time of the Arrangement (the "Effective Time"), the former Alcon shareholders will hold approximately 61% of the issued and outstanding common shares of Mexican Gold (the "Purchaser Shares") on a non-diluted basis.

ALC gains after launching Clareon TruPlus IOL, expanding its portfolio with enhanced depth of focus while maintaining high-quality distance vision.

FORT WORTH, Texas--(BUSINESS WIRE)--Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs, at ASCRS 2026.

GENEVA--(BUSINESS WIRE)--Alcon Publishes Agenda for 2026 Annual General Meeting.

GENEVA--(BUSINESS WIRE)--Alcon Publishes Agenda for 2026 Annual General Meeting.

Court preserves jury's finding of willful infringement by Alcon, and awards past damages to Sight Sciences in excess of $34 million and ongoing royalties through November 2028 Court preserves jury's finding of willful infringement by Alcon, and awards past damages to Sight Sciences in excess of $34 million and ongoing royalties through November 2028

ST. CATHARINES, Ontario--(BUSINESS WIRE)--Algoma Central Corporation (“Algoma” or the “Company”) (TSX:ALC), a leading provider of marine transportation services, announced today that the Toronto Stock Exchange (“TSX”) has accepted its notice of intention to proceed with the renewal of its normal course issuer bid (the “NCIB”). Algoma's Board of Directors believes that the market price of Algoma's common shares (“Shares”), from time to time, may not reflect the inherent value of the Company and.

Alcon is reaffirmed as a buy, supported by robust macro demand in eyecare and a strong product pipeline despite abandoning the STAAR Surgical acquisition. ALC demonstrates potential resilience versus market shocks, with favorable balance sheet risk and positive EPS forecasts for FY26. While ALC lags peers in some profitability metrics and offers only an annual 0.43% dividend, its low payout ratio and dividend growth provide some support to the dividend case.

GENEVA--(BUSINESS WIRE)--Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement.

ISRG, GMED, EW, ALC and IRMD show strong short-term upside as AI tools, acquisitions and new product pipelines fuel growth.

New English and Spanish editions of Understanding and Living with Glaucoma and first-ever Spanish audiobook aim to reach high-risk Hispanic communities Resources will be available during Glaucoma Awareness Week beginning March 9th SAN FRANCISCO, March 09, 2026 (GLOBE NEWSWIRE) -- Glaucoma Research Foundation (GRF) today announced a new partnership with Alcon, the global leader in eye care, to expand access to trusted, patient-centered glaucoma education for Spanish-speaking patients and families in the United States. Through Alcon's support, GRF will release an updated English and Spanish editions of its widely used “Understanding and Living with Glaucoma” booklet and introduce the first-ever Spanish audiobook version of this essential resource.
